It is a chemicals private limited company based in Ambala, Haryana, India, established in 2020.
2020 | Ambala, Haryana, India | ActiveEpazote Pharmaceuticals Private Limited, a active private limited company, was established on 01 September 2020 in Ambala, Haryana, India. Engaging in basic chemicals except fertilizers and nitrogen compounds within the chemicals sector, it holds CIN: U24110HR2020PTC088888. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Satyam Chopra (Additional Director), Vimal Chopra (Director). Past directors included Ashwani Chawla, Gurcharan Lal. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Shop No. 7, S.A. Jain College Road Opp. Shamshan Ghat, Shalimar Viharcolony, Ambala, Haryana, 134003.
U24110HR2020PTC088888
088888
01 September 2020
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Epazote Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyam Chopra | Additional Director | 03 May 2023 | Current |
| Vimal Chopra | Director | 01 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 May 2023 | Past |
| Pramod Abcsdd | Director | 03 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epazote Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Epazote Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Epazote Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Epazote Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epazote Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Satyam Chopra was appointed as a Additional Director was appointed as a Additional Director on 03 May 2023 & has been associated with this company since 2 years 7 months . was documented.
Progress on Epazote Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Progress on Epazote Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was documented.
The activity Vimal Chopra was appointed as a Director was appointed as a Director on 01 Sep 2020 & has been associated with this company since 5 years 3 months . was completed.
Epazote Pharmaceuticals Private Limited was registered on 01 Sep 2020 with Roc Delhi & aged 5 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Epazote Pharmaceuticals Private Limited is U24110HR2020PTC088888.
Epazote Pharmaceuticals Private Limited is headquartered at Shop No. 7, S.A. Jain College Road Opp. Shamshan Ghat, Shalimar Viharcolony, Ambala, Haryana, 134003.
Epazote Pharmaceuticals Private Limited was incorporated on 01 September 2020.
The current directors of Epazote Pharmaceuticals Private Limited are
The primary industry of Epazote Pharmaceuticals Private Limited is Chemicals.
Epazote Pharmaceuticals Private Limited is unlisted.
The authorized capital of Epazote Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX